A REVIEW ON OUT-OF-SPECIFICATION (OOS) RESULTS AND CORRECTIVE ACTION AND PREVENTIVE ACTION (CAPA)

Out-of-specification results represent a significant challenge in pharmaceutical industries, requiring through investigation to ensure product quality, regulatory compliance, and patient safety. An out-of-specification result occurs when a product or raw material test result falls outside the predefined acceptance criteria. The investigation of such results in crucial for identifying root causes, preventing recurrence, and ensuring the consistency of the manufacturing process. However, challenges such as complex root cause analysis, stringent timelines, cross-functional coordination, and maintaining data integrity makes these investigations difficult. Regulatory bodies like the food and drug administrative have established guidelines for handling out of specification results, emphasizing systematic laboratory and manufacturing process investigations. Effective out of specification management involves detailed documentation, cross-departmental collaborations, staff training, and proactive corrective actions to enhance product quality and compliance. This paper explores the critical nature of out of specification investigations and the approaches necessary to address the associated challenges in the pharmaceutical sector. Corrective action and preventive action is a system of quality practices necessary to remove the root causes of a current nonconformity to prevent the recurrence of nonconformity products, process, and other quality issues.